These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
383 related articles for article (PubMed ID: 15879305)
1. Vascular consequences of endothelial nitric oxide synthase uncoupling for the activity and expression of the soluble guanylyl cyclase and the cGMP-dependent protein kinase. Münzel T; Daiber A; Ullrich V; Mülsch A Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1551-7. PubMed ID: 15879305 [TBL] [Abstract][Full Text] [Related]
3. Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling. Mollnau H; Wendt M; Szöcs K; Lassègue B; Schulz E; Oelze M; Li H; Bodenschatz M; August M; Kleschyov AL; Tsilimingas N; Walter U; Förstermann U; Meinertz T; Griendling K; Münzel T Circ Res; 2002 Mar; 90(4):E58-65. PubMed ID: 11884382 [TBL] [Abstract][Full Text] [Related]
4. NADPH oxidase accounts for enhanced superoxide production and impaired endothelium-dependent smooth muscle relaxation in BKbeta1-/- mice. Oelze M; Warnholtz A; Faulhaber J; Wenzel P; Kleschyov AL; Coldewey M; Hink U; Pongs O; Fleming I; Wassmann S; Meinertz T; Ehmke H; Daiber A; Münzel T Arterioscler Thromb Vasc Biol; 2006 Aug; 26(8):1753-9. PubMed ID: 16763163 [TBL] [Abstract][Full Text] [Related]
5. Vasomotor control in mice overexpressing human endothelial nitric oxide synthase. van Deel ED; Merkus D; van Haperen R; de Waard MC; de Crom R; Duncker DJ Am J Physiol Heart Circ Physiol; 2007 Aug; 293(2):H1144-53. PubMed ID: 17496213 [TBL] [Abstract][Full Text] [Related]
6. Nebivolol prevents vascular NOS III uncoupling in experimental hyperlipidemia and inhibits NADPH oxidase activity in inflammatory cells. Mollnau H; Schulz E; Daiber A; Baldus S; Oelze M; August M; Wendt M; Walter U; Geiger C; Agrawal R; Kleschyov AL; Meinertz T; Münzel T Arterioscler Thromb Vasc Biol; 2003 Apr; 23(4):615-21. PubMed ID: 12692005 [TBL] [Abstract][Full Text] [Related]
7. Effects of 5-cyclopropyl-2-[1-(2-fluoro-benzyl)-1H-pyrazolo[3,4-b]pyridine-3-yl]pyrimidin-4-ylamine (BAY 41-2272) on smooth muscle tone, soluble guanylyl cyclase activity, and NADPH oxidase activity/expression in corpus cavernosum from wild-type, neuronal, and endothelial nitric-oxide synthase null mice. Teixeira CE; Priviero FB; Webb RC J Pharmacol Exp Ther; 2007 Sep; 322(3):1093-102. PubMed ID: 17596536 [TBL] [Abstract][Full Text] [Related]
8. Regulation of Sertoli cell tight junction dynamics in the rat testis via the nitric oxide synthase/soluble guanylate cyclase/3',5'-cyclic guanosine monophosphate/protein kinase G signaling pathway: an in vitro study. Lee NP; Cheng CY Endocrinology; 2003 Jul; 144(7):3114-29. PubMed ID: 12810568 [TBL] [Abstract][Full Text] [Related]
9. Regulation of the expression of soluble guanylyl cyclase by reactive oxygen species. Gerassimou C; Kotanidou A; Zhou Z; Simoes DC; Roussos C; Papapetropoulos A Br J Pharmacol; 2007 Apr; 150(8):1084-91. PubMed ID: 17339839 [TBL] [Abstract][Full Text] [Related]
10. Dynamic association of nitric oxide downstream signaling molecules with endothelial caveolin-1 in rat aorta. Linder AE; McCluskey LP; Cole KR; Lanning KM; Webb RC J Pharmacol Exp Ther; 2005 Jul; 314(1):9-15. PubMed ID: 15778264 [TBL] [Abstract][Full Text] [Related]
11. Understanding eNOS for pharmacological modulation of endothelial function: a translational view. Braam B; Verhaar MC Curr Pharm Des; 2007; 13(17):1727-40. PubMed ID: 17584103 [TBL] [Abstract][Full Text] [Related]
12. Effects of in vivo nitroglycerin treatment on activity and expression of the guanylyl cyclase and cGMP-dependent protein kinase and their downstream target vasodilator-stimulated phosphoprotein in aorta. Mülsch A; Oelze M; Klöss S; Mollnau H; Töpfer A; Smolenski A; Walter U; Stasch JP; Warnholtz A; Hink U; Meinertz T; Münzel T Circulation; 2001 May; 103(17):2188-94. PubMed ID: 11331261 [TBL] [Abstract][Full Text] [Related]
13. Mechanisms of increased vascular superoxide production in an experimental model of idiopathic dilated cardiomyopathy. Mollnau H; Oelze M; August M; Wendt M; Daiber A; Schulz E; Baldus S; Kleschyov AL; Materne A; Wenzel P; Hink U; Nickenig G; Fleming I; Münzel T Arterioscler Thromb Vasc Biol; 2005 Dec; 25(12):2554-9. PubMed ID: 16224052 [TBL] [Abstract][Full Text] [Related]
14. Pathophysiology, diagnosis and prognostic implications of endothelial dysfunction. Münzel T; Sinning C; Post F; Warnholtz A; Schulz E Ann Med; 2008; 40(3):180-96. PubMed ID: 18382884 [TBL] [Abstract][Full Text] [Related]
15. Effect of hypercholesterolemia and of oxidative stress on the nitric oxide-cGMP pathway. Francois M; Kojda G Neurochem Int; 2004 Nov; 45(6):955-61. PubMed ID: 15312990 [TBL] [Abstract][Full Text] [Related]
16. Nitric oxide-independent stimulation of soluble guanylate cyclase with BAY 41-2272 in cardiovascular disease. Boerrigter G; Burnett JC Cardiovasc Drug Rev; 2007; 25(1):30-45. PubMed ID: 17445086 [TBL] [Abstract][Full Text] [Related]
17. Role of the nitric oxide-soluble guanylyl cyclase pathway in obstructive airway diseases. Dupont LL; Glynos C; Bracke KR; Brouckaert P; Brusselle GG Pulm Pharmacol Ther; 2014 Oct; 29(1):1-6. PubMed ID: 25043200 [TBL] [Abstract][Full Text] [Related]
19. Functional and biochemical analysis of endothelial (dys)function and NO/cGMP signaling in human blood vessels with and without nitroglycerin pretreatment. Schulz E; Tsilimingas N; Rinze R; Reiter B; Wendt M; Oelze M; Woelken-Weckmüller S; Walter U; Reichenspurner H; Meinertz T; Münzel T Circulation; 2002 Mar; 105(10):1170-5. PubMed ID: 11889009 [TBL] [Abstract][Full Text] [Related]
20. Expression and activity of soluble guanylate cyclase in injury and repair of anti-thy1 glomerulonephritis. Peters H; Wang Y; Loof T; Martini S; Kron S; Krämer S; Neumayer HH Kidney Int; 2004 Dec; 66(6):2224-36. PubMed ID: 15569311 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]